Literature DB >> 15012033

First metatarsophalangeal joint arthrodesis.

Gerard V Yu1, Paul O Gorby.   

Abstract

First MTP joint arthrodesis continues to be a time-honored, effective, and valuable procedure as a primary or secondary surgery for various pathologies afflicting the first ray segment. Though commonly thought of as a salvage procedure, it has proven beneficial in the management of primary hallux limitus and rigidus, geriatric hallux valgus deformity, severe arthritis of any etiology, and conditions in which joint instability or deformity are not readily correctable by more traditional approaches. Since its initial description in the 1800s, the procedure has continued to be popular among orthopedic and podiatric surgeons. Success of the procedure is highly dependent on the position of fusion. Though surgeons are often fascinated and at times obsessed with a particular fixation technique, it cannot be over-emphasized that this takes a back seat to the importance of achieving proper position to meet the needs of an individual patient. Unlike joint resection or implant arthroplasty procedures, which commonly leave the hallux lacking stability and propulsion, first MPJ fusion has been shown to be effective during weight bearing and propulsion. The success enjoyed by the senior author continues to reinforce that motion is not necessary at the first MTP joint for good, pain-free function.

Entities:  

Mesh:

Year:  2004        PMID: 15012033     DOI: 10.1016/S0891-8422(03)00111-3

Source DB:  PubMed          Journal:  Clin Podiatr Med Surg        ISSN: 0891-8422            Impact factor:   1.231


  2 in total

1.  Complication rates in diabetics with first metatarsophalangeal joint arthrodesis.

Authors:  John J Anderson; Myron Hansen; Gregory Paul Rowe; Zflan Swayzee
Journal:  Diabet Foot Ankle       Date:  2014-06-27

2.  First metatarsophalangeal fusion with dorsal plate: clinical outcomes.

Authors:  Giuseppe Restuccia; Fabio Cosseddu; Andrea Del Chiaro; Matteo Ceccoli; Alessandro Lippi; Sheila Shytaj
Journal:  J Orthop Surg Res       Date:  2021-06-06       Impact factor: 2.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.